Immune responses and vaccine-induced immunity against Porcine circovirus type 2.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Veterinary Immunology and Immunopathology

• Publication date

  2010-08-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vetimm.2010.03.025PMID 20451259
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of different protocols of vaccination against porcine circovirus type 2 (PCV2) in a farm affected by postweaning multisystemic wasting syndrome (PMWS).

  2010cited by this paper
• Immunity conferred by an experimental vaccine based on the recombinant PCV2 Cap protein expressed in Trichoplusia ni-larvae.

  2010cited by this paper
• Fine mapping of antigenic epitopes on capsid proteins of porcine circovirus, and antigenic phenotype of porcine circovirus type 2.

  2009cited by this paper
• Effect of Porcine Circovirus Type 2 (PCV2) Vaccination of the Dam on PCV2 Replication In Utero

  2009cited by this paper
• Infection, excretion and seroconversion dynamics of porcine circovirus type 2 (PCV2) in pigs from post-weaning multisystemic wasting syndrome (PMWS) affected farms in Spain and Denmark.

  2009cited by this paper
• A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) improves clinical, pathological and virological outcomes in postweaning multisystemic wasting syndrome affected farms.

  2009cited by this paper
• One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model.

  2009cited by this paper
• Protective immunity against porcine circovirus 2 in mice induced by a gene‐based combination vaccination

  2009cited by this paper
• Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV-PCV2-SIV clinical infection model 2-3-months post vaccination.

  2009cited by this paper
• Cellular adaptive immune response against porcine circovirus type 2 in subclinically infected pigs

  2009cited by this paper
• Porcine circovirus diseases

  2009cited by this paper
• Use of a one-dose subunit vaccine to prevent losses associated with porcine circovirus type 2

  2009cited by this paper
• Construction and immunogenicity of recombinant pseudotype baculovirus expressing the capsid protein of porcine circovirus type 2 in mice.

  2008cited by this paper
• Post-weaning multisystemic wasting syndrome and other PCV2-related problems in pigs: a 12-year experience.

  2008cited by this paper
• Development of recombinant porcine parvovirus-like particles as an antigen carrier formed by the hybrid VP2 protein carrying immunoreactive epitope of porcine circovirus type 2.

  2008cited by this paper
• Porcine circoviruses: a minuscule yet mammoth paradox

  2008cited by this paper
• Protective immunity against porcine circovirus 2 by vaccination with ORF2-based DNA and subunit vaccines in mice.

  2008cited by this paper
• Porcine circovirus type 2 (PCV2) viral components immunomodulate recall antigen responses.

  2008cited by this paper
• Immunogenicity of porcine circovirus type 2 capsid protein targeting to different subcellular compartments.

  2008cited by this paper
• Development of cell-mediated immunity to porcine circovirus type 2 (PCV2) in caesarean-derived, colostrum-deprived piglets

  2008cited by this paper
• Targeting the porcine immune system—Particulate vaccines in the 21st century

  2008cited by this paper
• The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex.

  2008cited by this paper
• A meta-analysis on experimental infections with porcine circovirus type 2 (PCV2).

  2008cited by this paper
• Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins.

  2008cited by this paper
• Porcine circovirus type 2-induced interleukin-10 modulates recall antigen responses.

  2008cited by this paper
• Development of two Trichoplusia ni larvae-derived ELISAs for the detection of antibodies against replicase and capsid proteins of porcine circovirus type 2 in domestic pigs.

  2008cited by this paper
• Expression of the capsid protein of porcine circovirus type 2 in Lactococcus lactis for oral vaccination.

  2008cited by this paper
• A field evaluation of mortality rate and growth performance in pigs vaccinated against porcine circovirus type 2.

  2008cited by this paper
• Efficacy of immunising pigs against porcine circovirus type 2 at three or six weeks of age

  2008cited by this paper
• Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2.

  2008cited by this paper
• Systemic cytokine profiles of mice vaccinated with naked DNAs encoding six open reading frame antigens of porcine circovirus type 2 (PCV2).

  2008cited by this paper
• Silencing of natural interferon producing cell activation by porcine circovirus type 2 DNA

  2007cited by this paper
• A new method to identify cell types that support porcine circovirus type 2 replication in formalin-fixed, paraffin-embedded swine tissues.

  2007cited by this paper
• Structure-Dependent Modulation of Alpha Interferon Production by Porcine Circovirus 2 Oligodeoxyribonucleotide and CpG DNAs in Porcine Peripheral Blood Mononuclear Cells

  2007cited by this paper
• Quantification of PCV2 capsid transcript in peripheral blood mononuclear cells (PBMCs) in vitro.

  2007cited by this paper
• Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and non-PMWS-affected pigs.

  2007cited by this paper
• Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2.

  2007cited by this paper
• Sow porcine circovirus type 2 (PCV2) status effect on litter mortality in postweaning multisystemic wasting syndrome (PMWS).

  2007cited by this paper
• BMC Veterinary Research BioMed Central

  2007cited by this paper
• Porcine Circovirus Type 2–Associated Disease: Update on Current Terminology, Clinical Manifestations, Pathogenesis, Diagnosis, and Intervention Strategies

  2007cited by this paper
• Immunopathological effects of porcine circovirus type 2 (PCV2) on swine alveolar macrophages by in vitro inoculation.

  2006cited by this paper
• Cytokine and C-Reactive Protein Profiles Induced by Porcine Circovirus Type 2 Experimental Infection in 3-Week-Old Piglets

  2006cited by this paper
• Subset‐dependent modulation of dendritic cell activity by circovirus type 2

  2005cited by this paper
• Correlation Between Type of Adaptive Immune Response Against Porcine Circovirus Type 2 and Level of Virus Replication

  2005cited by this paper
• Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2.

  2005cited by this paper
• Reduction of porcine reproductive and respiratory syndrome virus (PRRSV) infection in swine alveolar macrophages by porcine circovirus 2 (PCV2)-induced interferon-alpha

  2005cited by this paper
• Experimental infection of 3-week-old conventional colostrum-fed pigs with porcine circovirus type 2 and porcine parvovirus.

  2005cited by this paper
• Porcine circovirus diseases

  2005cited by this paper
• Experimental reproduction of postweaning multisystemic wasting syndrome (PMWS) in pigs in Sweden and Denmark with a Swedish isolate of porcine circovirus type 2

  2005cited by this paper
• Systemic cytokine profile in feeder pigs suffering from natural postweaning multisystemic wasting syndrome (PMWS) as determined by semiquantitative RT-PCR and flow cytometric intracellular cytokine detection.

  2004cited by this paper
• Pathogenesis of postweaning multisystemic wasting syndrome caused by Porcine circovirus 2: an immune riddle

  2004cited by this paper
• Immunosuppression in postweaning multisystemic wasting syndrome affected pigs.

  2004cited by this paper
• Use of a polymerase chain reaction assay and an ELISA to monitor porcine circovirus type 2 infection in pigs from farms with and without postweaning multisystemic wasting syndrome.

  2004cited by this paper
• Porcine circovirus-2 and concurrent infections in the field.

  2004cited by this paper
• Interaction of classical swine fever virus with dendritic cells.

  2004cited by this paper
• Pathological findings associated with naturally acquired porcine circovirus type 2 associated disease.

  2004cited by this paper
• Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 in porcine circovirus 2-induced granulomatous inflammation.

  2004cited by this paper
• Characteristics of Porcine Circovirus—2 Replication in Lymphoid Organs of Pigs Inoculated in Late Gestation or Postnatally and Possible Relation to Clinical and Pathological Outcome of Infection

  2004cited by this paper
• A Chimeric Porcine Circovirus (PCV) with the Immunogenic Capsid Gene of the Pathogenic PCV Type 2 (PCV2) Cloned into the Genomic Backbone of the Nonpathogenic PCV1 Induces Protective Immunity against PCV2 Infection in Pigs

  2004cited by this paper
• Immunisation against PCV2 structural protein by DNA vaccination of mice.

  2004cited by this paper
• In vitro studies on the infection and replication of porcine circovirus type 2 in cells of the porcine immune system.

  2003cited by this paper
• Comparative serologic and virologic study of commercial swine herds with and without postweaning multisystemic wasting syndrome.

  2003cited by this paper
• Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins.

  2003cited by this paper
• Cytokine mRNA expression profiles in lymphoid tissues of pigs naturally affected by postweaning multisystemic wasting syndrome.

  2003cited by this paper
• Immunohistochemical characterisation of PCV2 associate lesions in lymphoid and non-lymphoid tissues of pigs with natural postweaning multisystemic wasting syndrome (PMWS)

  2003cited by this paper
• Dendritic Cells Harbor Infectious Porcine CircovirusType 2 in the Absence of Apparent Cell Modulation or Replication of theVirus

  2003cited by this paper
• Immunogenicity and Pathogenicity of Chimeric Infectious DNA Clones of Pathogenic Porcine Circovirus Type 2 (PCV2) and Nonpathogenic PCV1 in Weanling Pigs

  2003cited by this paper
• Identification of a sequence from the genome of porcine circovirus type 2 with an inhibitory effect on IFN-alpha production by porcine PBMCs.

  2003cited by this paper
• Experimental Reproduction of Postweaning Multisystemic Wasting Syndrome in Cesarean-Derived, Colostrum-Deprived Piglets Inoculated with Porcine Circovirus Type 2 (PCV2): Investigation of Quantitative PCV2 Distribution and Antibody Responses

  2003cited by this paper
• Association of lymphopenia with porcine circovirus type 2 induced postweaning multisystemic wasting syndrome (PMWS).

  2003cited by this paper
• An ORF2 protein-based ELISA for porcine circovirus type 2 antibodies in post-weaning multisystemic wasting syndrome

  2003cited by this paper
• Cytokine profiles of peripheral blood mononuclear cells from pigs with postweaning multisystemic wasting syndrome in response to mitogen, superantigen or recall viral antigens.

  2003cited by this paper
• Coinfection by Cryptosporidium parvum and porcine circovirus type 2 in weaned pigs.

  2003cited by this paper
• Reproduction of postweaning multisystemic wasting syndrome (PMWS) in immunostimulated and non-immunostimulated 3-week-old piglets experimentally infected with porcine circovirus type 2 (PCV2)

  2002cited by this paper
• Changes in CD4+, CD8+, CD4+ CD8+, and Immunoglobulin M-Positive Peripheral Blood Mononuclear Cells of Postweaning Multisystemic Wasting Syndrome-Affected Pigs and Age-Matched Uninfected Wasted and Healthy Pigs Correlate with Lesions and Porcine Circovirus Type 2 Load in Lymphoid Tissues

  2002cited by this paper
• Dynamics of porcine circovirus type 2 infection in a herd of pigs with postweaning multisystemic wasting syndrome.

  2002cited by this paper
• Immunologic Features of Porcine Circovirus Type 2 Infection

  2002cited by this paper
• Experimental Inoculation of Conventional Pigs with Porcine Reproductive and Respiratory Syndrome Virus and Porcine Circovirus 2

  2002cited by this paper
• Postweaning Multisystemic Wasting Syndrome Induced after Experimental Inoculation of Cesarean-Derived, Colostrum-Deprived Piglets with Type 2 Porcine Circovirus

  2001cited by this paper
• Bacterial expression of an immunologically reactive PCV2 ORF2 fusion protein.

  2001cited by this paper
• Activation of the Immune System is the Pivotal Event in the Production of Wasting Disease in Pigs Infected with Porcine Circovirus-2 (PCV-2)

  2001cited by this paper
• Immunohistochemical characterisation of the lymph node reaction in pig post-weaning multisystemic wasting syndrome (PMWS).

  2001cited by this paper
• Porcine circovirus induces B lymphocyte depletion in pigs with wasting disease syndrome.

  2000cited by this paper
• Characterization of Immune Response of Young Pigs to Porcine Circovirus Type 2 Infection

  2000cited by this paper
• Porcine Circoviruses: A Review

  2000cited by this paper
• Haematological parameters in postweaning multisystemic w syndrome-affeci

  2000cited by this paper
• Intestinal chiamydial infection concurrent with postweaning multisystemic wasting syndrome in pigs

  2000cited by this paper
• Experimental inoculation of conventional pigs with tissue homogenates from pigs with post-weaning multisystemic wasting syndrome.

  1999cited by this paper
• Experimental reproduction of severe wasting disease by co-infection of pigs with porcine circovirus and porcine parvovirus.

  1999cited by this paper
• Pathological, immunohistochemical, and in-situ hybridization studies of natural cases of postweaning multisystemic wasting syndrome (PMWS) in pigs.

  1999cited by this paper
• Effect of porcine circovirus infection on porcine alveolar macrophage function.

  1996cited by this paper

• Plant-Based Production and Immunogenicity Evaluation of a GCN4pII-Fused PCV2d Cap Protein in Mice

  2026cites this paper
• Infección por especies de circovirus porcino: interacción con el huésped y su potencial asociación con enfermedad

  2025cites this paper
• Speculative Review on the Feasibility of Porcine Circovirus 2 Elimination

  2025cites this paper
• Knowledge gaps in research and control of porcine circovirus 2 (PCV2) infections

  2025cites this paper
• Cellular immune signatures and differences of four porcine circovirus type 2 vaccines to heterologous PCV2d infection

  2025cites this paper
• Further evidence of the host plasticity of porcine circovirus-2: detection of the virus in domestic dogs in Namibia

  2025cites this paper
• Crystal structure of the ATPase domain of porcine circovirus type 2 Rep protein.

  2024cites this paper
• Newcastle Disease Virus Expressing Cap Gene of Porcine Circovirus Type 2 Confers Protection in Mice and Induced Long-Lasting Neutralizing Antibodies in Pigs

  2024cites this paper
• DUSP1 mRNA modulation during porcine circovirus type 2 and porcine reproductive and respiratory syndrome virus co-infection regulates viruses replication

  2023cites this paper
• Interaction between host cell proteins and open reading frames of porcine circovirus type 2

  2023influential citation
• Pathological features of the lungs and liver of piglets under conditions of constant vaccination of livestock against circovirus infection

  2023cites this paper
• Comparative Efficacy of Chimeric Porcine Circovirus (PCV) Vaccines against Experimental Heterologous PCV2d Challenges

  2023cites this paper
• Chinese yam polysaccharides PLGA-stabilized Pickering emulsion as an adjuvant system for PCV- 2 vaccine to enhance immune response.

  2022cites this paper
• Porcine Circovirus Type 2 Vaccines: Commercial Application and Research Advances

  2022cites this paper
• porcine circovirus infections

  2022cites this paper
• Maternal Immune Activation and Dietary Soy Isoflavone Supplementation Influence Pig Immune Function but not Muscle Fiber Formation.

  2022cites this paper
• PDZK1 upregulates nitric oxide production through the PI3K/ERK2 pathway to inhibit porcine circovirus type 2 replication.

  2022cites this paper
• Efficacy Studies of a Trivalent Vaccine Containing PCV-2a, PCV-2b Genotypes and Mycoplasma hyopneumoniae When Administered at 3 Days of Age and 3 Weeks Later against Porcine Circovirus 2 (PCV-2) Infection

  2022cites this paper
• Single-stranded circular DNA theranostics

  2022cites this paper
• Exploratory field study on the effects of porcine circovirus 2 (PCV-2) sow vaccination at different physiological stages mimicking blanket vaccination

  2021cites this paper
• Nuclear transporter karyopherin subunit alpha 3 levels modulate Porcine circovirus type 2 replication in PK-15 cells.

  2020cites this paper
• Reduction of Postweaning Multisystemic Wasting Syndrome-Associated Clinical Symptoms by Virus-Like Particle Vaccine Against Porcine Parvovirus and Porcine Circovirus Type 2

  2020cites this paper
• Porcine Dendritic Cells and Viruses: An Update

  2019cites this paper
• Identification of a novel cluster of PCV2 isolates from Meghalaya, India indicates possible recombination along with changes in capsid protein.

  2019cites this paper
• Generation and Immunogenicity of a Recombinant Pseudorabies Virus Co-Expressing Classical Swine Fever Virus E2 Protein and Porcine Circovirus Type 2 Capsid Protein Based on Fosmid Library Platform

  2019cites this paper
• Sargassum polysaccharide inhibits inflammatory response in PCV2 infected-RAW264.7 cells by regulating histone acetylation.

  2018cites this paper
• ERK MAPK signaling pathway regulates porcine circovirus type 2 replication in peripheral blood mononuclear cells

  2018cites this paper
• Porcine circovirus 2 infection induces IFNβ expression through increased expression of genes involved in RIG-I and IRF7 signaling pathways.

  2018cites this paper
• POST WEANING MULTISYSTEMIC WASTING SYNDROME : AN EMERGING DISEASE OF SWINE-AN OVERVIEW

  2017cites this paper
• Porcine Circovirus Type 2 (PCV2) Vaccines in the Context of Current Molecular Epidemiology

  2017cites this paper
• Global Status of Porcine circovirus Type 2 and Its Associated Diseases in Sub-Saharan Africa

  2017cites this paper
• The Hsp90 inhibitor 17-DMAG decreases infection of porcine circovirus type 2 in mice.

  2017cites this paper
• Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli.

  2016cites this paper
• Latent porcine circovirus type 2-infected domestic pigs: A potential infection model for the effective development of vaccines against latent or chronic virus induced diseases.

  2016cites this paper
• National reduction in porcine circovirus type 2 prevalence following introduction of vaccination.

  2016cites this paper
• Adición de Enterococcus faecium mejora poblaciones celulares inmunes y anticuerpos vacunales de lechones destetos

  2016cites this paper
• Interactions of porcine circovirus 2 with its hosts

  2016cites this paper
• Diagnostic testing for swine respiratory viruses using oral fluids in Saskatchewan

  2016cites this paper
• New insights on PCV2 vaccination: thinking out of the box

  2015influential citation
• A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.

  2015cites this paper
• Porcine circovirus 2 immunology and viral evolution

  2015cites this paper
• Genetic variability of porcine circovirus 2 (PCV2) field isolates from vaccinated and non-vaccinated pig herds in Germany.

  2015cites this paper
• PCV2 vaccination induces IFN-γ/TNF-α co-producing T cells with a potential role in protection

  2015cites this paper
• Assessment of neutralizing and non-neutralizing antibody responses against Porcine circovirus 2 in vaccinated and non-vaccinated farmed pigs.

  2015cites this paper
• Virological and serological characterization of vaccinated and non-vaccinated piglet subpopulations coming from vaccinated and non-vaccinated sows.

  2015cites this paper
• Vaccination of pigs reduces Torque teno sus virus viremia during natural infection.

  2015cites this paper
• Effect of atovastatin treatment on porcine circovirus 2 infection in BALB/c mice

  2015cites this paper
• Zakażenia cirkowirusowe świń - aktualna klasyfikacja oraz kryteria diagnostyczne

  2015cites this paper
• Novel approaches towards vaccine developments against porcine circovirus type 2 and porcine reproductive and respiratory syndrome virus

  2015cites this paper
• Torque teno sus viruses: pathogenesis in co-infection with Porcine circovirus type 2 and humoral immune responses during natural infection of pigs

  2015cites this paper
• Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies

  2014cites this paper
• Protective Immunity vs . Immunopathogenesis : Recognition of the Structural form of the PCV 2 Capsid Determines the Outcome

  2014cites this paper
• Genetic variability of porcine circovirus 2 in vaccinating and non-vaccinating commercial farms.

  2014cites this paper
• The porcine innate immune system: An update

  2014cites this paper
• Influence of porcine circovirus type 2 vaccination on the probability and severity of pneumonia detected postmortem

  2014cites this paper
• Memory T cell proliferative responses and IFN-γ productivity sustain long-lasting efficacy of a Cap-based PCV2 vaccine upon PCV2 natural infection and associated disease

  2014cites this paper
• Pesquisa e caracterização genética de amostras do Torque teno sus virus 1 e 2 circulantes em suínos domésticos do estado de São Paulo e Porco Monteiro do Pantanal

  2014cites this paper
• Immune responses of mice immunized by DNA plasmids encoding PCV2 ORF 2 gene, porcine IL-15 or the both.

  2013cites this paper
• Construction and immunogenicity of recombinant porcine circovirus-like particles displaying somatostatin.

  2013cites this paper
• Porcine circovirus type 2 stimulates plasmacytoid dendritic cells in the presence of IFN-gamma.

  2013cites this paper
• Innate pro-inflammatory and adaptive immune cytokines in PBMC of vaccinated and unvaccinated pigs naturally exposed to porcine circovirus type 2 (PCV2) infection vary with the occurrence of the disease and the viral burden.

  2013cites this paper
• Induction of mucosal immunity by intranasal immunization with recombinant adenovirus expressing major epitopes of Porcine circovirus-2 capsid protein.

  2013cites this paper
• The natural history of porcine circovirus type 2: from an inoffensive virus to a devastating swine disease?

  2013cites this paper
• Expression of recombinant porcine circovirus 2 (PCV2) capsid polypeptides for mapping antibody epitopes following vaccination, infection, and disease

  2012cites this paper
• Infectious risk factors for individual postweaning multisystemic wasting syndrome (PMWS) development in pigs from affected farms in Spain and Denmark.

  2012cites this paper
• Investigation of porcine circovirus contamination in human vaccines.

  2012cites this paper
• Fatal bronchopneumonia in a Metastrongylus elongatus and Porcine circovirus type 2 co-infected pig.

  2012cites this paper
• Development and Application of a Double-Antigen Sandwich Enzyme-Linked Immunosorbent Assay for Detection of Antibodies to Porcine Circovirus 2

  2012cites this paper
• Commercial porcine circovirus type 2 vaccines: efficacy and clinical application.

  2012cites this paper
• Porcine circovirus type 2 (PCV2) infections: clinical signs, pathology and laboratory diagnosis.

  2012cites this paper
• Role of Torque teno sus viruses during co-infection with other swine pathogens

  2012cites this paper
• Emerging and re-emerging swine viruses.

  2012cites this paper
• Immunology of porcine circovirus type 2 (PCV2).

  2012cites this paper
• Porcine circovirus diseases: a review of PMWS.

  2012cites this paper
• Subclinical porcine circovirus infection: what lies beneath.

  2012cites this paper
• Inactivated PCV2 one shot vaccine applied in 3-week-old piglets: improvement of production parameters and interaction with maternally derived immunity.

  2012cites this paper
• Lack of effect of piglet vaccination against Porcine circovirus type 2 (PCV2) on serum viral loads of Torque teno sus virus 2 (TTSuV2).

  2012cites this paper
• Development and application of a double-antigen sandwich ELISA

  2012cites this paper
• Effect of sow and piglet porcine circovirus type 2 (PCV2) vaccination on piglet mortality, viraemia, antibody titre and production parameters.

  2012cites this paper
• Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine.

  2012cites this paper
• Subclinical porcine circovirus type 2 infection does not modulate the immune response to an Aujeszky's disease virus vaccine.

  2012cites this paper
• Torque teno sus virus 1 and 2 viral loads in postweaning multisystemic wasting syndrome (PMWS) and porcine dermatitis and nephropathy syndrome (PDNS) affected pigs.

  2011cites this paper
• Intestinal gene expression in pigs experimentally co-infected with PCV2 and PPV.

  2011cites this paper
• Dynamics of Torque teno sus virus 1 (TTSuV1) and 2 (TTSuV2) DNA loads in serum of healthy and postweaning multisystemic wasting syndrome (PMWS) affected pigs.

  2011cites this paper
• Quantitative assessment of Lawsonia intracellularis in feces by real-time PCR

  2010cites this paper
• Novel chimeric porcine circovirus (PCV) with the capsid gene of the emerging PCV2b subtype cloned in the genomic backbone of the non-pathogenic PCV1 is attenuated in vivo and induces protective and cross-protective immunity against PCV2b and PCV2a subtypes in pigs.

  2010cites this paper
• Circoviruses

  2008cites this paper